Semaglutide is a GLP-1 receptor agonist, while tirzepatide targets two pathways (GLP-1 and GIP)
Drinking on an empty stomach can increase your risk of low blood sugar (hypoglycaemia) and stop your blood-alcohol level from spiking
These drugs, originally approved for type 2 diabetes and now weight loss, lower A1c, slow digestion to increase satiety, increase fat utilization, and have led to dramatic weight loss results of around 12%25% body weight after 52 weeks of use
Zepbound is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm
resume daily activities immediately Our medical weight loss injection program offers a non-surgical, physician-guided solution to help you achieve and maintain a healthy weight